Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN)

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 60, Issue 3, 2005, Pages 361-372

  Göppert, Torsten M ^a   Müller, Rainer H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Poloxamer; Poloxamine; Protein adsorption patterns; Site specific drug delivery; Solid lipid nanoparticles; Two dimensional polyacrylamide gel electrophoresis

Indexed keywords

ACID; APOLIPOPROTEIN; BICINCHONINIC ACID; CETYL PALMITATE; MACROGOL; PALMITIC ACID DERIVATIVE; PLASMA PROTEIN; POLOXAMER; POLOXAMINE 908; SOLID LIPID NANOPARTICLE; STABILIZING AGENT; UNCLASSIFIED DRUG;

ADSORPTION; ARTICLE; CORRELATION ANALYSIS; DRUG STABILITY; PROTEIN DETERMINATION; PROTEIN INTERACTION;

ADSORPTION; BLOOD PROTEINS; DRUG CARRIERS; DRUG STABILITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ETHYLENEDIAMINES; HUMANS; NANOSTRUCTURES; PARTICLE SIZE; POLOXAMER; POLYETHYLENE GLYCOLS; SURFACE PROPERTIES;

EID: 21544437915     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2005.02.006     Document Type: Article

References (48)

1. P. Ehrlich Collected Studies on Immunity 1906 Wiley New York pp. 586
2. D.J. Wilkens, and P.A. Meyers Studies on the relationship between the electrophoretic properties of colloids and their blood clearance and organ distribution in the rat Br. J. Exp. Pathol. 47 1966 568 576
3. L. Illum, S.S. Davis, R.H. Müller, E. Mak, and P. West The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer-poloxamine 908 Life Sci. 40 4 1987 367 374
4. R.H. Müller Colloidal Carriers for Controlled Drug Delivery and Targeting - Modification Characterization and in vivo Distribution 1991 CRC Press Boca Raton, FL pp. 379
5. R.H. Müller, and S. Heinemann Surface modelling of microparticles as parenteral systems with high tissue affinity R. Gurny H.E Junginger Bioadhesion - Possibilities and Future Trends 1989 Wissenschaftliche Stuttgart, Germany 202 214
6. T. Blunk, D.F. Hochstrasser, J.-C. Sanchez, B.W. Müller, and R.H. Müller Colloidal carriers for intravenous drug targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis Electrophoresis 14 12 1993 1382 1387
7. R.H. Müller, D. Rühl, M. Lück, and B.R. Paulke Influence of fluorescent labelling of polystyrene particles on phagocytic uptake, surface hydrophobicity, and plasma protein adsorption Pharm. Res. 14 1 1997 18 24
8. T. Blunk, M. Lück, A. Calvör, D.F. Hochstrasser, J.-C. Sanchez, B.W. Müller, and R.H. Müller Kinetics of plasma protein adsorption on model particles for controlled drug delivery and drug targeting Eur. J. Pharm. Biopharm. 42 1996 262 268
9. L. Illum, I.M. Hunneyball, and S.S. Davis The effect of hydrophilic coatings on the uptake of colloidal particles by the liver and by peritoneal macrophages Int. J. Pharm. 29 1986 53 65
10. R. Alyautdin, D. Gothier, V. Petrov, D. Kharkevich, and J. Kreuter Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles Eur. J. Pharm. Biopharm. 41 1995 44 48
11. R.N. Alyautdin, E.B. Tezikov, P. Ramge, D.A. Kharkevich, D.J. Begley, and J. Kreuter Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study J. Microencapsul. 15 1 1998 67 74
12. A.E. Gulyaev, S.E. Gelperina, I.N. Skidan, A.S. Antropov, G.Y. Kivman, and J. Kreuter Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles Pharm. Res. 16 10 1999 1564 1569
13. R.H. Müller, M. Lück, J. Kreuter, Medicament excipient particles for tissue specific application of a medicament, PCT-application PCT/EP98/064299 (P53601), 2001.
14. J. Kreuter, C.G. Wilson, J.R. Fry, P. Paterson, and J.H. Ratcliffe Toxicity and association of polycyanoacrylate nanoparticles with hepatocytes J. Microencapsul. 1 3 1984 253 257
15. R.H. Müller, S. Maassen, H. Weyhers, and W. Mehnert Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407 J. Drug Target 4 3 1996 161 170
16. H. Weyhers, S. Ehlers, W. Mehnert, H. Hahn, R.H. Müller, Solid Lipid Nanoparticles - determination of in vivo toxicity, Proceedings of the First World Meeting APGI/APV, Budapest, 1995, pp. 489-490.
17. H. Weyhers, Feste Lipid Nanopartikel (SLN) für die gewebsspezifische Arzneistoffapplikation, Freie Universität Berlin, Department of Pharmacy, Berlin, 1995.
18. L. Illum, and S.S. Davis Targeting of colloidal particles to the bone marrow Life Sci. 40 16 1987 1553 1560
19. D.W. Miller, E.V. Batrakova, T.O. Waltner, V. Alakhov, and A.V. Kabanov Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption Bioconjug. Chem. 8 5 1997 649 657
20. E.V. Batrakova, S. Li, D.W. Miller, and A.V. Kabanov Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers Pharm. Res. 16 9 1999 1366 1372
21. D.F. Hochstrasser, M.G. Harrington, A.C. Hochstrasser, M.J. Miller, and C.R. Merril Methods for increasing the resolution of two-dimensional protein electrophoresis Anal. Biochem. 173 2 1988 424 435
22. R.H. Müller, J.S. Lucks, Arzneistoffträger aus festen Lipidteilchen, Feste Lipidnanosphären (SLN), European Patent EP 0605497, 1996.
23. R.H. Müller, K. Mäder, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 1 2000 161 177
24. B.C. Cook, and G.S. Retzinger Elution of fibrinogen and other plasma protein from unmodified and from lecithin-coated polystyrene-divinylbenzene beads J. Colloid Interf. Sci. 153 1992 1 12
25. B. Bjellqvist, C. Pasquali, F. Ravier, J.C. Sanchez, and D.F. Hochstrasser A nonlinear wide-range immobilized pH gradient for two-dimensional electrophoresis and its definition in a relevant pH scale Electrophoresis 14 12 1993 1357 1365
26. N.L. Anderson, and N.G. Anderson A two-dimensional gel database of human plasma proteins Electrophoresis 12 11 1991 883 906
27. H.-M. Poehling, and V. Neuhof Visualization of proteins with a silver 'stain': a critical analysis Electrophoresis 2 1981 141 147
28. P.K. Smith, R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimoto, N.M. Goeke, B.J. Olson, and D.C. Klenk Measurement of protein using bicinchoninic acid Anal. Biochem. 150 1 1985 76 85
29. A. Gessner, A. Lieske, B.R. Paulke, and R.H Müller Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis Eur. J. Pharm. Biopharm. 54 2 2002 165 170
30. A. Gessner, A. Lieske, B.R. Paulke, R.H. Müller, Functional groups on polystyrene model particles: influence on protein adsorption, J. Biomed. Mater. Res., submitted for publication.
31. A. Gessner, Untersuchungen zur Proteinadsorption auf kolloidalen Modellpartikeln und Arzneistoffträgern zur parenteralen Anwendung, Freie Universität Berlin, Department of Pharmacy, Berlin, 2001
32. J.H. Lee, and J.D. Andrade Surface properties of aqueous PEO/PPO block copolymer surfactants J.D. Andrade Polymer Surface Dynamics 1988 Plenum Press New York 119 136
33. R. Gref, M. Lück, P. Quellec, M. Marchand, E. Dellacherie, S. Harnisch, T. Blunk, and R.H. Müller 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption Colloids Surf. B. Biointerfaces 18 3-4 2000 301 313
34. M.A. Carignano, and I.I. Szleifer Prevention of protein adsorption by flexible and rigid chain molecules Colloids Surf. B. Biointerfaces 18 3-4 2000 169 182
35. A. Gessner, B.-R. Paulke, R.H. Müller, Protein rejecting properties of PEG-grafted nanoparticles: influence of PEG-chain length and surface density evaluated by two-dimensional electrophoresis and bicinchoninic acid (BCA)-proteinassay, Electrophoresis, accepted.
36. B.W. Müller, and R.H. Müller Particle size analysis of latex suspensions and microemulsions by photon correlation spectroscopy J. Pharm. Sci. 73 7 1984 1915 1918
37. S.D. Tröster, and J. Kreuter Contact angle of surfactants with a potential to alter the body distribution of colloidal drug carriers on poly (methyl methacrylate) surfaces Int. J. Pharm. 45 1988 91 100
38. V. Galazka, A.M. Khan, M.C. Davies, and R.H. Müller Effect of gamma-irradiation and plasma etching on the surface of polymers Arch. Pharm. 320 1987 980
39. S. Rudt, and R.H. Müller In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. II. Effect of surface modification by coating of particles with poloxamer on the phagocytic uptake J. Contr. Rel. 25 1993 51 59
40. S. Rudt, and R.H. Müller In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. III. Uptake of differently sized surface-modified particles, and its correlation to particle properties and in vivo distribution Eur. J. Pharm. Sci. 1 1993 31 39
41. S. Rudt, H. Wesemeyer, and R.H. Müller In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. IV. Effect of surface modification by coating of particles with poloxamine and antarox CO on the phagocytic uptake J. Contr. Rel. 25 1993 123 132
42. N. Schöler, K. Krause, O. Kayser, R.H. Müller, K. Borner, H. Hahn, and O. Liesenfeld Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis Antimicrob. Agents Chemother. 45 6 2001 1771 1779
43. J. Kreuter Nanoparticulate systems for brain delivery of drugs Adv. Drug Deliv. Rev. 47 1 2001 65 81
44. T. Blunk, Plasmaproteinadsorption auf kolloidalen Arzneistoffträ gern, Christian-Albrechts-Universität zu Kiel, Department of Pharmacy, Kiel, 1994
45. K.H. Weisgraber, R.W. Mahley, R.C. Kowal, J. Herz, J.L. Goldstein, and M.S. Brown Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein J. Biol. Chem. 265 36 1990 22453 22459
46. L. Illum, and S.S. Davis Effect of the nonionic surfactant poloxamer 338 on the fate and deposition of polystyrene microspheres following intravenous administration J. Pharm. Sci. 72 9 1983 1086 1089
47. A. Gessner, C. Olbrich, W. Schröder, O. Kayser, and R.H. Müller The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles Int. J. Pharm. 214 1-2 2001 87 91
48. C.L. Bisgaier, M.V. Siebenkas, and K.J. Williams Effects of apolipoproteins A-IV and A-I on the uptake of phospholipid liposomes by hepatocytes J. Biol. Chem. 264 2 1989 862 866